Although the above findings, when taken together, provide strong evidence that uPA and PAI-1 were independent prognostic biomarkers in breast cancer, they were insufficient for these biomarkers to be recommended for routine clinical use. This evidence concerns the gene SERPINE1 and breast cancer.